Gradalis Company
Gradalis is engaged in manufacturing immunotherapy for the treatment of cancer.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
Carrollton, Texas, United States
Founded Date:
2003-01-01
Employees Number:
11-50
Total Funding:
67936167
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-04-02
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership